Literature DB >> 3081632

Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens.

D A Thorley-Lawson, S L Swendeman, C M Edson.   

Abstract

The biochemical processing of the BLAST-1 and BLAST-2 activation antigens has been studied. Both are glycoproteins that derive from different precursors of the same apparent m.w. on SDS-PAGE. BLAST-1 is synthesized as a 43,000 m.w. light chain in association with a second heavier chain of 55,000 m.w. The light chain acquires sialylated O-linked glycans and is stably expressed at the cell surface with a half-life of 14 hr. BLAST-2 is also synthesized as a 43,000 m.w. precursor, but it acquires only unsialylated N-linked glycans. The mature glycoprotein is only expressed briefly at the cell surface (half-life of 1 to 2 hr), and is then shed into the culture supernatant as a soluble 33,000 m.w. derivative. The different fates of these molecules, one stably expressed at the cell surface and one shed, suggest disparate roles for these two antigens in B cell activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081632

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

Authors:  A Calender; M Billaud; J P Aubry; J Banchereau; M Vuillaume; G M Lenoir
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Immunohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis.

Authors:  E A Hellen; D C Rowlands; T T Hansel; G D Kitas; J Crocker
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 3.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

4.  c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.

Authors:  Kristina T Lu; Frank L Sinquett; Rebecca L Dryer; Charles Song; Lori R Covey
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

5.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.

Authors:  P D Ling; J J Hsieh; I K Ruf; D R Rawlins; S D Hayward
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.

Authors:  M Birkenbach; K Josefsen; R Yalamanchili; G Lenoir; E Kieff
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.

Authors:  G R Guy; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.

Authors:  J Gordon; A J Webb; G R Guy; L Walker
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

9.  The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

Authors:  S Swendeman; D A Thorley-Lawson
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  Molecular cloning of the lymphocyte activation marker Blast-1.

Authors:  D E Staunton; D A Thorley-Lawson
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.